Scamuffa N, Basak A, Lalou C, Wargnier A, Marcinkiewicz J, Siegfried G, Chrétien M, Calvo F, Seidah N G, Khatib A-M
INSERM U 716/Equipe AVENIR, Institut de Génétique Moléculaire, 27 rue Juliette Dodu, 75010 Paris, France.
Gut. 2008 Nov;57(11):1573-82. doi: 10.1136/gut.2007.141812. Epub 2008 Jul 29.
Hepcidin is an iron homoeostasis regulator peptide. Loss-of-function mutations cause juvenile haemochromatosis while its over-expression results in anaemia. However, the mechanism and function of preprohepcidin conversion to mature hepcidins (25, 22 and 20 amino acid C-terminal peptides) are not well known. After removal of the signal peptide, the first proteolytic cleavage occurs within the basic motif RRRRR(59)DT, suggesting the involvement of proprotein convertase (PC) family members in this process.
Using cell transfection experiments, the processing of preprohepcidin in the human hepatocyte line Huh-7 was found to be inhibited by the Furin inhibitors serpin alpha1-antitrypsin (alpha1-PDX) and prosegment preproFurin (ppFurin). Site-directed mutagenesis analysis confirmed the RRRRR(59)DT preprohepcidin cleavage site. In parallel, the lack of preprohepcidin processing found in the PC activity-deficient cell line LoVo was restored by the expression of Furin, paired basic amino acid cleaving enzyme 4 (PACE4), PC5 or PC7. This finding is consistent with the in vitro digestions of a synthetic peptide mimicking the cleavage site of preprohepcidin. In addition, during mouse embryonic development the major expression of hepcidin found in the liver coincided with that of Furin. While hepcidin induces the degradation of the iron transporter ferroportin, its RRRRR(59) to SSSSS(59) mutant is not active.
These results demonstrate the key role of the convertases Furin, PACE4, PC5 and/or PC7 in the generation and secretion of active hepcidin and suggest that the control of hepcidin processing as a potential therapeutic/diagnostic strategy in hepcidin-related disorders such as haemochromatosis, inflammatory diseases, anaemia and cancer.
铁调素是一种铁稳态调节肽。功能丧失性突变会导致青少年血色素沉着症,而其过度表达则会导致贫血。然而,前体铁调素转化为成熟铁调素(25、22和20个氨基酸的C末端肽)的机制和功能尚不清楚。在去除信号肽后,第一次蛋白水解切割发生在碱性基序RRRRR(59)DT内,这表明前蛋白转化酶(PC)家族成员参与了这一过程。
通过细胞转染实验发现,弗林蛋白酶抑制剂丝氨酸蛋白酶抑制剂α1-抗胰蛋白酶(α1-PDX)和前体片段前弗林蛋白酶(ppFurin)可抑制人肝细胞系Huh-7中前体铁调素的加工过程。定点诱变分析证实了RRRRR(59)DT前体铁调素切割位点。同时,通过表达弗林蛋白酶、成对碱性氨基酸裂解酶4(PACE4)、PC5或PC7,恢复了PC活性缺陷细胞系LoVo中前体铁调素加工的缺失。这一发现与模拟前体铁调素切割位点的合成肽的体外消化结果一致。此外,在小鼠胚胎发育过程中,肝脏中铁调素的主要表达与弗林蛋白酶的表达一致。虽然铁调素可诱导铁转运蛋白铁输出蛋白的降解,但其RRRRR(59)至SSSSS(59)突变体无活性。
这些结果证明了弗林蛋白酶、PACE4、PC5和/或PC7在活性铁调素的产生和分泌中起关键作用,并表明控制铁调素的加工过程可作为血色素沉着症、炎症性疾病、贫血和癌症等与铁调素相关疾病的潜在治疗/诊断策略。